For U.S. residents only.

Patient Navigators

< Back To Site

Prescribing Info including Patient Info

IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING AND APPROVED USE

QTc Prolongation and Sudden Death: TASIGNA can cause QTc prolongation, a possibly life-threatening heart problem. QTc prolongation causes an irregular heartbeat, which may lead to sudden death. Call y...

Approved Uses:

TASIGNA^® (nilotinib) capsules is a prescription medicine used to treat:

Adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
Adults with Ph+ CML in chronic phase and accelerated phase who no longer benefit from, or ...

Let a navigator be your guide as you start Tasigna

The Novartis Patient Navigator Program is staffed by a team of specialists who are available to support you during your treatment journey.* Once enrolled in the program, you will receive a series of phone calls from a specially trained navigator who will support and guide you through various aspects of initiating your prescribed medicine.^†

Novartis Patient Navigators:

Educate on product attributes: for example, dosing and administration, side effects, and monitoring recommendations
Provide information on lifestyle support during treatment
Educate on the benefits investigation process: review the results and out-of-pocket responsibilities
Provide access to disease education materials and guide patients to other Novartis resources where applicable

To learn more about the Patient Navigator Program, contact Patient Assistance Now Oncology (PANO) at 1-800-282-7630, prompt 3.

*The Novartis Patient Navigator Program is available for select Novartis Oncology products. Patient Navigator services do not involve the practice of nursing or provide clinical advice and counseling.

^†Must be prescribed a Novartis Oncology medicine for an approved indication that is offered within the Patient Navigator Program.

Enroll now in the Novartis Patient Navigator Program

To sign up for a Patient Navigator for TASIGNA^® (nilotinib) capsules, please fill out the form below, and then click “Submit” when you’re finished. You must be 18 years of age or older to participate in this program.

1/1:Enter Your Information

*Required fields.

First Name*

Last Name*

Gender *

Male

Female

Street Address*

City*

Zip Code*

E-mail

Telephone Number*

OK to leave detailed voice mail about your medication on your phone *

Yes

Physician First Name*

Physician Last Name*

Office Contact Number*

Type of Insurance *

Commercial/Private

Medicare/Medicaid

Uninsured

I am taking TASIGNA for an approved use, consistent with the product’s Prescribing Information. See below for approved uses.*

By clicking submit, I confirm I’d like to enroll in the Patient Navigator Program, and agree to receive recurring phone calls from a Novartis Patient Navigator at the number(s) provided. Calls may be prerecorded or autodialed. Consent and participation in the Program is not a condition of purchase of a product or service.

Please complete all required fields.

Next: Helpful Materials